Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

411 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.
Thierry AR, El Messaoudi S, Mollevi C, Raoul JL, Guimbaud R, Pezet D, Artru P, Assenat E, Borg C, Mathonnet M, De La Fouchardière C, Bouché O, Gavoille C, Fiess C, Auzemery B, Meddeb R, Lopez-Crapez E, Sanchez C, Pastor B, Ychou M. Thierry AR, et al. Among authors: bouche o. Ann Oncol. 2017 Sep 1;28(9):2149-2159. doi: 10.1093/annonc/mdx330. Ann Oncol. 2017. PMID: 28911069 Free article.
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801).
Bouché O, Ychou M, Burtin P, Bedenne L, Ducreux M, Lebreton G, Baulieux J, Nordlinger B, Martin C, Seitz JF, Tigaud JM, Echinard E, Stremsdoerfer N, Milan C, Rougier P; Fédération Francophone de Cancérologie Digestive Group. Bouché O, et al. Ann Oncol. 2005 Sep;16(9):1488-97. doi: 10.1093/annonc/mdi270. Epub 2005 Jun 6. Ann Oncol. 2005. PMID: 15939717 Free article. Clinical Trial.
[Recommendations for clinical practice: management of stomach adenocarcinoma].
Ychou M, Bouché O, Marchal F, Merrouche Y, Gory-Delabaere G; Standards, Options et Recommandations; Institut national du cancer; Fédération nationale des centres de lutte contre le cancer (FNCLCC); Ligue nationale contre le cancer; Fédération hospitalière de France; Fédération nationale de cancérologie des CHRU (FNCHRU); Fédération française de Cancérologie. Ychou M, et al. Among authors: bouche o. Bull Cancer. 2006 Feb;93(2):192-6. Bull Cancer. 2006. PMID: 16521331 Free article. Review. French. No abstract available.
[Recommendations for clinical practice: management with first-line palliative chemotherapy for patients with metastatic colorectal cancer].
Conroy T, Adeni A, Bouché O, Merrouche Y, Mitry E, Gory-Delabaere G; Standards, Options et Recommandations; Institut national du cancer; Fédération nationale des centres de lutte contre le cancer; Ligue nationale contre le cancer; Société nationale française de Gastro-Entérologie; FFCD; GERCOR; Fédération hospitalière de France; Fédération nationale de Cancérologie des CHRU; Fédération française de cancérologie des CHG. Conroy T, et al. Among authors: bouche o. Bull Cancer. 2006 Feb;93(2):197-200. Bull Cancer. 2006. PMID: 16521333 Free article. Review. French. No abstract available.
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer.
Bonnetain F, Bouché O, Michel P, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Paillot B, Arveux P, Milan C, Bedenne L. Bonnetain F, et al. Among authors: bouche o. Ann Oncol. 2006 May;17(5):827-34. doi: 10.1093/annonc/mdl033. Epub 2006 Mar 8. Ann Oncol. 2006. PMID: 16524973 Free article. Clinical Trial.
Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial.
Ducreux M, Bouche O, Pignon JP, Mousseau M, Raoul JL, Cassan P, Leduc B, Berger C, Dunant A, Fournet J, Bedenne L; FFCD 9601 Collaborative Group. Ducreux M, et al. Among authors: bouche o. Oncology. 2006;70(3):222-30. doi: 10.1159/000094357. Epub 2006 Jun 30. Oncology. 2006. PMID: 16816536 Clinical Trial.
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).
Ychou M, Raoul JL, Douillard JY, Gourgou-Bourgade S, Bugat R, Mineur L, Viret F, Becouarn Y, Bouché O, Gamelin E, Ducreux M, Conroy T, Seitz JF, Bedenne L, Kramar A. Ychou M, et al. Among authors: bouche o. Ann Oncol. 2009 Apr;20(4):674-80. doi: 10.1093/annonc/mdn680. Epub 2009 Jan 29. Ann Oncol. 2009. PMID: 19179549 Free article. Clinical Trial.
Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment.
Samalin E, Afchain P, Thézenas S, Abbas F, Romano O, Guimbaud R, Bécouarn Y, Desseigne F, Edeline J, Mitry E, Bouché O, Adenis A, Aparicio T, Dorval E, Kramar A, Ychou M. Samalin E, et al. Among authors: bouche o. Clin Res Hepatol Gastroenterol. 2011 Jan;35(1):48-54. doi: 10.1016/j.gcb.2010.06.010. Clin Res Hepatol Gastroenterol. 2011. PMID: 21634054
411 results